Facebook
X
LinkedIn
ForwardBridging the Gaps: A Patient-Centered Approach to Selecting Novel Oral Anticoagulants
Hospital-based clinicians face the everyday challenge of providing individualized, safe, and effective care for patients with atrial fibrillation (AF). A greater understanding of this disorder, including an update on CHADS2 and CHA2DS2-VASc indices for stroke risk assessment and 2014, and the updated AHA, ACC, and ESC ACA/AHA/HRS evidence-based treatment recomendations inclusive of, as well as a review of current and emerging oral anticoagulant therapies, and provision of educational tools from the ACPF Atrial Fibrillation and Stroke Prevention Intiative, are critical to engaging patients in shared decision making and maximizing patient outcomes.
METHOD OF PARTICIPATION
In order to receive full credit and obtain a certificate for participating in this activity, participants must review the accreditation information, view the online activity and complete the online evaluation with a 70% passing score on the posttest by going to http://www.rapidcme.com/activity.aspx?actID=49. Credit cannot be awarded unless all steps are completed.
***PLEASE KNOW THAT YOU WILL NOT RECEIVE A CERTIFICATE THROUGH THE DUKE LMS AND THE CREDIT WILL NOT BE REFLECTED ON YOUR TRANSCRIPT.***
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Apply stroke risk stratification consistently to patients with AF in everyday practice using available tools and evidence-based guidelines to select those patients requiring anticoagulation.
- Calculate net benefit-risk, based on the safety and efficacy of the therapy and individual patient profiles when considering which anticoagulant therapies to recommend to AF patients.
- Utilize educational tools from the ACP Foundation Atrial Fibrillation and Stroke Prevention Intiative and shared decision making with AF patients to determine personalized stroke prevention regimens.